Novo Nordisk AS (NVO)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$66.95

Buy

$67.16

arrow-up$2.65 (+4.12%)

Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.
Prices updated at 20 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.09%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$67.03 - $64.87
$148.15 - $57.00
2.43
289,248.59m
19.03
-
11,194,289
14.33
6,585,175.96
0.66
4,465.00m
US6701002056
23.48
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.